NDC product
Uretron D/S
NDC 12539-144 · DORAL PHARMAMEDICS INC dba A.G. Marin Pharmaceuticals
Key facts
| Product NDC | 12539-144 |
|---|---|
| Proprietary name | Uretron D/S |
| Nonproprietary name | Methenamine, Sodium Phosphate Monobasic, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
| Substances | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, HYOSCYAMINE SULFATE, METHYLENE BLUE, METHENAMINE |
| Dosage form | TABLET |
| Route | ORAL |
| Labeler | DORAL PHARMAMEDICS INC dba A.G. Marin Pharmaceuticals |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Pharmacologic classes | Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC] |
| Marketing start | Oct 7, 2022 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: